Session Information
ASHP Summer Meeting 2007
Click here to go to the previous page
The 340B Drug Pricing Program: Optimizing the Value, Ensuring Compliance, and Improving Access (Hot Topic)
Track:
Educational Sessions
Program Code: 107-L04
Date: Monday, June 25, 2007
Time: 2:00 PM to 5:00 PM
Location:
3014
SPEAKER(S):
Shari D. Dees, RPh, Director of Pharmacy, Pharmacy Department, Magnolia Hospital, Magnolia, AR
Mr. Christopher Hatwig, M.S., R.Ph., President, 340B Prime Vendor Program, Apexus
Danny J. Jackson, RPh, BS, Director of Pharmacy Services, Louisiana State University (LSU) Health Care Services-Huey P. Long Medical Center, Pineville, Coordinator of Pharmacy Standardization, LSU Health Sciences Center-Health Care Services Division, Baton Rouge
William H. von Oehsen, AB, MTS, JD, Principal, Powers, Pyles, Sutter & Verville, PC, General Counsel, Safety Net Hospitals for Pharmaceutical Access, Washington, DC
Rory E. Phillips, BSPharm, Director of Pharmacy Services, Department of Pharmacy, Southern Ohio Medical Center, Portsmouth
Robert Scholz, Administrator of District Services, Harris County Hospital District, Houston, TX
Billy W. Woodward, RPh, Senior Consultant, Ernst & Young, LLP
Description
Walk through a typical hospital evaluation process to discover appropriate implementation strategies for ensuring compliance with regulatory requirements while optimizing program savings. Learn about the voluntary Prime Vendor Program and its role in negotiating sub-340B discounts on pharmaceuticals as well as other discounts on products and services. Hear various examples of hospitals' experience with 340B Drug Pricing, its unique challenges and benefits, and its impact on improving access to affordable pharmaceuticals.